Söndag 5 Januari | 08:13:08 Europe / Stockholm

Bifogade filer

Kalender

Tid*
2025-11-06 13:30 Kvartalsrapport 2025-Q3
2025-08-21 13:30 Kvartalsrapport 2025-Q2
2025-05-08 13:30 Kvartalsrapport 2025-Q1
2025-02-27 08:00 Bokslutskommuniké 2024
2024-12-18 - Extra Bolagsstämma 2024
2024-11-07 - Kvartalsrapport 2024-Q3
2024-08-21 - Kvartalsrapport 2024-Q2
2024-05-16 - X-dag ordinarie utdelning STENO 0.00 DKK
2024-05-15 - Årsstämma
2024-05-02 - Kvartalsrapport 2024-Q1
2024-02-22 - Bokslutskommuniké 2023
2023-11-09 - Kvartalsrapport 2023-Q3
2023-08-17 - Kvartalsrapport 2023-Q2
2023-06-20 - Kvartalsrapport 2023-Q1
2023-06-13 - Extra Bolagsstämma 2023
2023-05-22 - X-dag ordinarie utdelning STENO 0.00 DKK
2023-02-23 - Bokslutskommuniké 2022
2022-11-18 - Extra Bolagsstämma 2022
2022-11-09 - Kvartalsrapport 2022-Q3
2022-08-18 - Kvartalsrapport 2022-Q2
2022-05-20 - X-dag ordinarie utdelning STENO 0.00 DKK
2022-05-19 - Årsstämma
2022-05-05 - Kvartalsrapport 2022-Q1
2022-02-24 - Bokslutskommuniké 2021
2021-11-04 - Kvartalsrapport 2021-Q3
2021-08-19 - Kvartalsrapport 2021-Q2
2021-05-21 - X-dag ordinarie utdelning STENO 0.00 DKK
2021-05-20 - Årsstämma
2021-05-06 - Kvartalsrapport 2021-Q1
2021-02-25 - Bokslutskommuniké 2020
2020-11-05 - Kvartalsrapport 2020-Q3
2020-08-20 - Kvartalsrapport 2020-Q2
2020-05-15 - X-dag ordinarie utdelning STENO 0.00 DKK
2020-05-14 - Årsstämma
2020-05-07 - Kvartalsrapport 2020-Q1
2020-02-26 - Bokslutskommuniké 2019
2019-11-06 - Kvartalsrapport 2019-Q3
2019-08-20 - Kvartalsrapport 2019-Q2
2019-05-07 - Kvartalsrapport 2019-Q1
2019-02-21 - Bokslutskommuniké 2018

Beskrivning

LandDanmark
ListaFirst North Denmark
SektorHälsovård
IndustriLäkemedel & Handel
Stenocare är verksamt inom hälsovårdsindustrin. Bolaget är specialiserat inom utveckling av medicinsk cannabis. Stenocare är en av de första aktören att ha påbörjat försäljning av medicinska cannabisoljor i Danmark. Bolaget kommer framöver även vända sig till övriga europeiska marknader med sitt produktutbud. Stenocares huvudkontor ligger i Randers.
2024-11-28 22:14:53

STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK

TICKER:  STENO

Today, the Danish parliament formally agreed on permanent legalisation of medical cannabis. This is fantastic news for both Danish patients and Stenocare, as it ensures continued access to and the sale of medical cannabis in Denmark

The Ministry of Interior and Health announced today that the political parties have decided to permanently legalise treatment with medical cannabis in Denmark. When the Danish Pilot Programme expires in December 2025, the Danish Parliament will enact legislation to ensure the permanent legalisation of medical cannabis treatment for patients. This is fantastic news for Danish patients, who now have certainty that they can continue their treatment. For Stenocare, it also provides a positive outlook for the Danish domestic market, where the company has been a leading supplier of prescription medical cannabis since 2018.

The Minister of Interior and Health, Sophie Løhde, commented on today's agreement:

"Medical cannabis has proven to be a sought-after alternative to authorised medication for patients with serious diseases such as cancer and multiple sclerosis. Many experiences relief from pain or nausea that can significantly improve their quality of life. And with this agreement, we ensure that patients who have not had sufficient effect from other treatments will continue to be able to be prescribed medical cannabis by a doctor in a safe environment."

The political parties also agreed to enhance information and guidance for both doctors and patients. This includes providing treatment guidelines for doctors and permitting patients to continue driving while undergoing treatment with medical cannabis. Stenocare views this as a significant victory for Danish patients, the company, and the medical cannabis industry, as it helps to normalise medical cannabis treatment and position it alongside other forms of medication.

Stenocare CEO, Thomas Skovlund Schnegelsberg, commented:

"Since 2017, Stenocare's mission has been to improve the quality of life for patients in need of treatment for severe illnesses. In Denmark, the Pilot Programme has allowed patients to benefit from medical cannabis treatment, and we view the decision to permanently legalise medical cannabis as a strong endorsement of our mission. We are very pleased that medical cannabis is now officially recognised as part of the treatment regime in Denmark."

Read the official press release from the Minister of Interior and Health (only in Danish): Ny aftale: Ordning med medicinsk cannabis på recept bliver permanent | Indenrigs- og Sundhedsministeriet